Table 3

Comparison between low and high hepatic insulin clearance

ParametersHIC <6.5HIC >6.5P value
(n=10)(n=11)
Age (years)58.3±11.060.2±10.6N.S.
Sex (male/female)4/66/5N.S.
BMI (kg/m2)29.9±2.7624.1±4.3<0.001
Duration of diabetes (years)2.8±4.64.6±4.6N.S.
Fasting plasma glucose (mmol/L)7.12±0.577.18±1.44N.S.
Postprandial plasma glucose 2 hours (mmol/L)9.68±2.1011.45±2.080.06
AST (U/L)39.6±23.025.3±6.7N.S.
ALT (U/L)63.0±44.136.6±15.6N.S.
Gamma-GTP (U/L)77.2±62.630.0±13.00.01
HbA1c (%)7.10±0.758.10±0.53<0.001
HOMA-beta (%)102.6±23.335.7±24.0<0.001
Insulinogenic Index1.09±1.220.24±0.11<0.001
C-peptide-AUC0–301.98±0.691.16±0.33<0.005
C-peptede-AUC0–1204.02±1.322.43±0.57<0.005
HOMA-IR5.89±1.772.17±1.89<0.005
GDR (mg/kg/min)5.19±1.916.22±2.10N.S.
M/I4.34±1.8910.09±9.15<0.05
Adiponectin (μg/mL)3.92±3.436.75±8.45<0.05
GLP-1 AUC6.99±2.838.91±4.81N.S.
GIP AUC109.70±39.53102.30±43.99N.S.
Glucagon AUC225.76±103.56123.26±104.750.09
  • Data are presented as the mean±SD.

  • The comparison of parameters between low and high hepatic insulin clearance was performed using the Mann-Whitney U test. The χ2 test was used for categorical comparisons of the sex data.

  • ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUC, area under the curve; BMI, body mass index; GDR, glucose disposal rate; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide-1; GTP, glutamyl transpeptidase; HbA1c, glycated hemoglobin; HIC, hepatic insulin clearance; HOMA-beta, homeostatic model assessment beta cell function; HOMA-IR, homeostasis model assessment for insulin resistance; N.S., not significant.